Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_provenance.
- NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_assertion description "[As we have recently shown, inhibitors of histone deacetylases, in particular, valproic acid (VA), were capable of up-regulating NEP expression and activity in human neuroblastoma SH-SY5Y cell lines characterised by very low levels of NEP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_provenance.
- NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_assertion evidence source_evidence_literature NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_provenance.
- NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_assertion SIO_000772 21932040 NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_provenance.
- NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_assertion wasDerivedFrom befree-2016 NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_provenance.
- NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_assertion wasGeneratedBy ECO_0000203 NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_provenance.
- befree-2016 importedOn "2016-02-19" NP924957.RAbTR4a1HnvRztR9gN6VhQ9GlrSiBLnY6_ReAZoYmMuFo130_provenance.